Related by context. All words. (Click for frequent words.) 70 brain shrinkage 64 hippocampal volume 64 cognitive decline 63 cognitive impairment 62 hippocampal atrophy 61 glucose metabolism 60 cognitively normal 60 coronary calcification 59 rCBF 59 parkinsonism 59 ventricular enlargement 59 mild cognitive impairment 59 plasma homocysteine levels 58 metabolic abnormalities 58 neuropathological 58 amyloid deposition 58 carotid atherosclerosis 58 cardiorespiratory fitness 58 insulin resistance 58 cerebral atrophy 58 impaired cognition 58 glucose tolerance 58 folate deficiency 58 Alzheimer pathology 58 cognitive function 58 diastolic function 58 carotid IMT 58 autonomic dysfunction 58 fat oxidation 57 subclinical hypothyroidism 57 locomotor activity 57 MMSE scores 57 maintaining cardiorespiratory fitness 57 extrapyramidal symptoms 57 tau pathology 57 Depressive symptoms 56 muscle protein synthesis 56 cardiovascular mortality 56 cortisol secretion 56 telomere shortening 56 dementia 56 NAFLD 56 neurodegeneration 56 white matter hyperintensities 56 apoE4 56 colorectal adenomas 56 fasting glucose levels 56 infarcts 56 flow mediated dilation 56 knee osteoarthritis 56 elevated triglyceride levels 56 cerebral infarction 56 neurocognitive deficits 56 arterial thickening 56 colorectal adenoma 56 hypoperfusion 56 mild cognitive 55 nondemented 55 MS relapses 55 disease progression 55 hyperinsulinemia 55 telomere length 55 fasting insulin 55 cognitive dysfunction 55 amnestic MCI 55 insulin sensitivity 55 prostate cancer CaP 55 serum cholesterol 55 gallstone disease 55 urate levels 55 endothelial dysfunction 55 Alzheimer Disease AD 55 microalbuminuria 55 airflow obstruction 55 cognitive deficits 55 hepatic steatosis 55 calcium excretion 55 neurodevelopmental outcomes 55 CVD mortality 55 psychosocial functioning 55 atherosclerosis 55 airflow limitation 55 T2DM 55 fatty acid oxidation 55 SRBD 55 glucose intolerance 55 serum vitamin D 55 intermittent hypoxia 55 Scarmeas 55 cortical thinning 55 penetrance 55 gastric emptying 55 Aß 55 APOC3 55 Insulin sensitivity 55 growth hormone secretion 55 bone resorption 55 telomere lengths 55 Concord grape juice 54 knee OA 54 hippocampal volumes 54 vasodilatation 54 disease NAFLD 54 nerve degeneration 54 subclinical atherosclerosis 54 intima media thickness 54 PAOD 54 liver fibrosis 54 serum lipids 54 esophageal adenocarcinoma 54 SLC#A# [002] 54 estrogen deficiency 54 arterial calcification 54 brain lesions 54 T1DM 54 neurological abnormalities 54 neurocognitive function 54 APOE4 54 hippocampal function 54 PSADT 54 plasma leptin 54 metabolic dysfunction 54 carotid artery thickness 54 adiposity 54 atherosclerotic lesions 54 Multivariate analyzes 54 disc degeneration 54 atherosclerotic lesion 54 neurological degeneration 54 elevated homocysteine 54 Endothelial function 54 depressive symptomatology 54 motor neuron degeneration 54 abstinent alcoholics 54 abdominal adiposity 54 symptomatic VTE 54 triiodothyronine 54 MetS 54 cataract formation 54 plasma homocysteine 54 chronic pancreatitis 54 CLA supplementation 54 amyloid β 54 atherosclerotic disease 54 hypertrophy 54 thyroid dysfunction 54 postmenopausal breast cancer 54 microvascular dysfunction 54 leptin resistance 54 neuropsychiatric symptoms 54 neuronal dysfunction 53 sporadic ALS 53 GBA mutations 53 kidney dysfunction 53 dietary calcium intake 53 cardio respiratory fitness 53 depressive symptoms 53 remyelination 53 left ventricular hypertrophy 53 HOMA IR 53 hepatic fibrosis 53 subcortical 53 Subgroup analysis 53 donepezil 53 HPA axis 53 progressive neurodegenerative disorder 53 neurodevelopmental impairment 53 proliferative diabetic retinopathy 53 Cognitive impairment 53 cortical thickness 53 serum calcium 53 diastolic dysfunction 53 mRNA expression 53 lipid profiles 53 metabolic acidosis 53 tHcy 53 atherogenesis 53 amyloid pathology 53 Wernicke Korsakoff syndrome 53 transaminase levels 53 ventricular remodeling 53 aortic atherosclerosis 53 prolactin levels 53 thyroid hormone levels 53 dopamine signaling 53 GH deficiency 53 adiponectin 53 ovarian hormones 53 glucose homeostasis 53 mammary tumors 53 prefrontal cortical 53 leptin deficient mice 53 serum testosterone 53 anticholinergic drugs 53 5 HT1A 53 dermatomyositis 53 serum BDNF 53 arterial stiffness 53 fibrosis 53 nonalcoholic steatohepatitis NASH 53 capillary density 53 Genetic variants 53 Parkinsonism 53 medial temporal 53 arterial stiffening 53 VaD 53 androgen deficiency 53 mitochondrial function 53 Klinefelter syndrome 53 adenoma 53 RBP4 53 chronic prostatitis 53 hyperintense lesions 53 SHBG levels 53 hyperhomocysteinemia 53 inflammatory markers 53 vascular dementia 53 serum calcium levels 53 urinary excretion 53 cardiac dysfunction 53 glycosylated hemoglobin HbA1c 53 lung function 52 serum estradiol 52 plasma triglycerides 52 metabolic parameters 52 GH secretion 52 Mild cognitive impairment 52 tryptophan depletion 52 NAT2 52 leukocyte counts 52 RYGB surgery 52 neuroprotective effects 52 blood glucose concentrations 52 dietary antioxidants 52 dentate gyrus 52 neuroimaging studies 52 systolic dysfunction 52 fetuin 52 atherogenic dyslipidemia 52 carotid stenosis 52 myelination 52 dietary glycemic index 52 multi infarct dementia 52 aldosterone 52 serum cortisol 52 glomerular filtration 52 serum phosphate 52 body fatness 52 platelet activation 52 spastic diplegia 52 neurologic symptoms 52 homocysteine concentrations 52 nonmelanoma skin cancers 52 Hashimoto thyroiditis 52 glycated hemoglobin levels 52 Alzheimers disease 52 cryptorchidism 52 vessel dilation 52 H. pylori infection 52 haemorrhagic stroke 52 galanin 52 insulin secretion 52 nocturnal hypoglycemia 52 pressure natriuresis 52 triacylglycerol concentrations 52 subclinical hyperthyroidism 52 mitochondrial mutations 52 benign breast 52 axonal damage 52 magnesium intake 52 alkalosis 52 reflux symptoms 52 FTLD 52 airway hyperresponsiveness 52 IDDM 52 vitamin B# deficiency 52 AAT deficiency 52 hepatic glucose production 52 hypersomnia 52 serum urate levels 52 cystatin C 52 repolarization 52 infantile hemangioma 52 bone mineral 52 impaired glucose metabolism 52 microglial 52 ACh 52 prothrombotic 52 serum folate 52 metabolic syndrome MetS 52 CatB 52 generalized seizures 52 serum PSA 52 left ventricular systolic 52 hirsutism 52 protein excretion 52 glomerular filtration rate 52 elevated serum creatinine 52 contractility 52 serum triglycerides 52 HIV HCV coinfected 52 cholinergic tone 52 cortical atrophy 52 cardiovascular disease 52 elevated cortisol 52 endothelial function 52 alcoholic fatty liver 52 somatic symptoms 52 nonobese 52 intravascular hemolysis 52 fatty liver disease 52 familial ALS 52 gastro oesophageal reflux 52 daytime sleepiness 52 glucocorticoid 52 prefrontal regions 52 plasma lipids 52 cardiac fibrosis 52 Sleep disturbances 52 metabolic disturbances 52 muscle hypertrophy 52 normotensive 52 CREB protein 52 aMCI 52 factor BDNF 52 platelet aggregation 52 recurrent VTE 52 cartilage degeneration 52 atypical neuroleptics 52 interstitial lung abnormalities 52 perimenopausal women 52 gallstone formation 52 artery calcification 52 aortic stiffness 52 BPH symptoms 52 systemic inflammation 52 atrophic gastritis 52 adrenal function 52 optic neuritis 52 SORL1 51 baroreceptor 51 multivariable analysis 51 myocardial ischemia 51 myocardial dysfunction 51 myo inositol 51 amyloid plaque 51 idiopathic Parkinson disease 51 hyperphenylalaninemia HPA due 51 RBP4 levels 51 XLHED 51 vasodilation 51 retinal degeneration 51 glycemia 51 microbleeds 51 hypoxemia 51 skeletal muscle mass 51 liver scarring 51 affective disorder 51 infarct size 51 amnestic mild cognitive impairment 51 steatohepatitis 51 gait disturbances 51 metabolic syndrome 51 asymptomatic carotid stenosis 51 B# deficiency 51 alexithymia 51 central adiposity 51 myocardial fibrosis 51 metabolic 51 behavioral abnormalities 51 platelet clumping 51 circadian clock genes 51 hormone leptin 51 endometrial cancer 51 allopregnanolone 51 progranulin 51 polycystic ovary syndrome PCOS 51 rs# [003] 51 neuroleptics 51 Chronic pancreatitis 51 behavioral disinhibition 51 Obstructive sleep apnea 51 severe hypoglycemia 51 adiponectin levels 51 Korsakoff syndrome 51 postoperative delirium 51 choroidal neovascularization 51 HNSCC 51 onset seizures 51 DRD2 51 myoclonus 51 LQTS 51 androgen depletion 51 muscarinic receptors 51 Sarcopenia 51 neuro degeneration 51 prostate cancer PCa 51 selenium supplementation 51 microglial activation 51 hyperglycaemia 51 prepubertal 51 de ath 51 oxidative stress 51 bladder contractions 51 CC genotype 51 aneurysmal subarachnoid hemorrhage 51 ADPKD 51 choroidal neovascularization CNV 51 cognitive functioning 51 heterozygotes 51 euthyroid 51 intracranial hypertension 51 foveal thickness 51 knee osteoarthritis OA 51 kidney function 51 microvascular complications 51 HDL2 51 induced ischemia 51 KIBRA 51 sarcopenia 51 airway remodeling 51 colorectal carcinoma 51 bradykinesia 51 airway constriction 51 onset diabetes mellitus 51 APOE ε4 51 neurodevelopmental outcome 51 synaptic function 51 nondepressed 51 handgrip strength 51 baroreflex 51 inhibitory transmitter 51 hyperammonemia 51 preserved ejection fraction 51 nonfasting triglycerides 51 beta blocker therapy 51 atrioventricular block 51 nonfasting triglyceride levels 51 natriuresis 51 systolic hypertension 51 Sjögren syndrome 51 GSTP1 51 hepatic cirrhosis 51 cytopenias 51 intracranial haemorrhage 51 fructose intake 51 urinary symptoms 51 cirrhosis 51 caloric restriction 51 autoimmune thyroiditis 51 neurogenesis 51 neuronal function 51 VUR 51 #q# deletion syndrome 51 daytime drowsiness 51 antioxidant supplementation 51 serum testosterone levels 51 vascular reactivity 51 LRRK2 mutations 51 SHBG 51 malignant transformation 51 amyloid beta plaque 51 fenretinide 51 malabsorption 51 albuminuria 51 DHEAS 51 improves insulin sensitivity 51 artery stenosis 51 androgenic alopecia 51 renal fibrosis 51 neuro degenerative disease 51 rs# [002] 51 ischemic stroke 51 da mage 51 stone formers 51 premenstrual syndrome PMS 51 oxidative damage 51 synaptic plasticity 51 proliferative retinopathy 51 vascular dysfunction 51 G allele 51 primary ovarian insufficiency 51 gadolinium enhanced 51 MMSE score 51 folate intake 51 neuronal degeneration 51 fronto temporal dementia 51 colorectal neoplasia 51 corrected QT interval 51 salivary flow 51 autoregulation 51 neuropathologic 51 Peutz Jeghers syndrome 51 cortical activation 51 intracerebral hemorrhage 51 hormones leptin 51 glycemic diet 51 neuritic plaques 51 UCP2 51 elevated ALT 51 claudication 50 insulin resistance syndrome 50 coronary artery atherosclerosis 50 lipid abnormalities 50 hyperplastic 50 dietary carbohydrate 50 thyrotropin 50 elevated LDH 50 Vascular dementia 50 prostate carcinogenesis 50 euthymic patients 50 bronchopulmonary dysplasia 50 familial adenomatous polyposis 50 CP CPPS 50 mammographic density 50 apnea hypopnea index 50 lowest tertile 50 nondiabetic 50 serum IGF 50 collagen degradation 50 BACE1 50 delayed gastric emptying 50 phthalate exposure 50 APOE allele 50 p# activation 50 thyrotropin levels 50 amenorrhea 50 hyperreflexia 50 SGPT 50 cortisol levels 50 recurrent venous thromboembolism 50 glycogen metabolism 50 amyloid plaque formation 50 neovascular 50 systolic function 50 mitochondrial respiration 50 hydrops 50 alanine aminotransferase ALT 50 EBV infection 50 amyloid deposits 50 multivariate adjustment 50 predisposing factor 50 oxygen desaturation 50 cerebellar 50 impaired glucose tolerance 50 serum parathyroid hormone 50 salivary cortisol 50 Insulin resistance 50 folic acid deficiency 50 APOE e4 50 macrovascular 50 activated microglia 50 parkinsonian symptoms 50 CETP gene 50 RLS symptoms 50 Alzheimer's related 50 hsCRP levels 50 serum leptin 50 acetabular dysplasia 50 aminotransferases 50 antihypertensive therapy 50 HDL C 50 atrophic 50 overactivity 50 leukemia AML 50 biochemical imbalance 50 urinary calcium 50 serum folate concentrations 50 nonvertebral fractures 50 renal dysfunction 50 ApoE4 50 folates 50 neovascularization 50 frontotemporal dementia 50 logistic regression analysis 50 CAG repeats 50 neutrophil counts 50 telomerase activity 50 tau proteins 50 hypercalcaemia 50 endometrial hyperplasia 50 Alzheimer disease 50 Korsakoff 50 cardiac abnormalities 50 COMT 50 MTHFR 50 homocysteine levels 50 intermittent claudication 50 glycated hemoglobin HbA1c 50 nonfatal MI 50 Daytime sleepiness 50 OAB symptoms 50 plasma folate 50 gene variant 50 carotid plaque 50 thyroid function 50 hyperintensity 50 cortical excitability 50 creatine supplementation 50 uric acid levels 50 polyp recurrence 50 Clinical Endocrinology & 50 liver cirrhosis 50 arcuate nucleus 50 reinfarction 50 subclinical inflammation 50 serum creatinine levels 50 LDL cholesterol concentrations 50 elevated depressive symptoms 50 lobular breast cancer 50 left ventricular diastolic 50 physiological arousal 50 ob ob mice 50 carotid plaques 50 Mild Cognitive Impairment 50 utero exposure 50 Binge eating 50 Critical limb ischemia 50 Leitzmann 50 dyskinesias 50 anterior temporal 50 SIRT1 50 neuropsychiatric disorder 50 CHD mortality 50 isolated systolic hypertension 50 intact parathyroid hormone 50 malignant lymphoma 50 kalirin 50 demyelination 50 noncarriers 50 Excessive daytime sleepiness 50 hypothalamic 50 contractile function 50 albumin excretion 50 hippocampal dysfunction 50 dopamine synthesis 50 urinary oxalate 50 embolic stroke 50 Neurology Neurosurgery 50 neuropeptide Y 50 IBS symptoms 50 Ghrelin 50 glutamatergic 50 neurocognitive dysfunction 50 Calcium intake 50 neurotransmitter GABA 50 SCD1 50 β amyloid 50 Univariate analysis 50 plasma fibrinogen 50 persistent pulmonary hypertension 50 nephritis 50 C reactive protein 50 diabetic kidney 50 liver metastasis 50 cardiac autonomic 50 spermatogenesis 50 A1 allele 50 neurofibrillary 50 mixed hyperlipidemia 50 shorter telomeres 50 premenopausal 50 plaque buildup 50 pulmonary exacerbation 50 quantitative EEG 50 pernicious anemia 50 lung fibrosis 50 plasma lipid 50 mitochondrial dysfunction 50 posterior cingulate 50 hypothalamic pituitary adrenal axis 50 fatty acid metabolism 49 osteosarcomas 49 impaired fasting glucose 49 schizophrenia CIAS 49 primary aldosteronism 49 hypogonadal 49 proband 49 ventricular mass 49 obese postmenopausal 49 physiological abnormalities 49 Homocysteine 49 psychotic symptoms 49 Aβ 49 subclinical 49 clinically insignificant 49 hyperexcitability 49 left ventricular LV 49 QTc interval 49 amino acid homocysteine 49 unmeasured confounders 49 hippocampal 49 neurocognitive impairment 49 brain derived neurotrophic 49 Wernicke encephalopathy 49 fatty liver 49 genital abnormalities 49 atrophy 49 testicular tumors 49 hypovitaminosis D 49 androgen excess 49 nonischemic 49 postoperative AF 49 autoantibody levels 49 neuropathology 49 colorectal tumors 49 leptin deficient 49 pCR 49 coronary disease 49 diastolic BP 49 abdominal obesity 49 nonalcoholic steatohepatitis 49 serum PTH 49 preterm delivery 49 diabetes insipidus 49 inducible nitric oxide synthase 49 elevated triglycerides 49 bowel polyps 49 PMS symptoms 49 protein tau 49 MSMB 49 daytime alertness 49 endocrine tumors 49 CHRNA5 gene 49 amenorrhoea 49 Osteopenia 49 Leydig cell 49 testosterone supplementation 49 hypertensives 49 QTc intervals 49 neurologic dysfunction 49 leptin 49 cranial irradiation 49 hormone secretion 49 glutamate signaling 49 parkinsonian 49 neuronal activity 49 neurodevelopmental disability 49 Abeta# 49 HbF 49 autosomal dominant disorder 49 hemorrhagic strokes 49 infarctions 49 QT intervals 49 dietary folate 49 tHcy concentrations 49 exhaled nitric oxide 49 involution 49 lactate dehydrogenase LDH 49 hyperoxia 49 vascular inflammation 49 adenotonsillectomy 49 Moderate drinkers 49 neuroinflammation 49 highest tertile 49 QTc 49 proinflammatory cytokines 49 elevated CRP 49 muscle wastage 49 rs# [004] 49 acute myelogenous leukemia AML 49 UCP1 49 adenoma recurrence 49 SIDS infants 49 transthyretin 49 metabolite concentrations 49 atherosclerotic cardiovascular disease 49 alanine aminotransferase 49 overactivation 49 akathisia 49 acid secretion 49 2D 4D ratio 49 VADT 49 plasma creatinine 49 BDNF protein 49 activate AMPK 49 progressive degeneration 49 cardiometabolic risk 49 gastric atrophy 49 VMAT2 49 COX2 49 lipid accumulation 49 myelosuppression 49 cardiac hypertrophy 49 gastric carcinoma 49 elevated uric acid 49 diabetes mellitus DM 49 secondary hyperparathyroidism 49 Kaplan Meier analysis 49 calcitriol 49 remnant lipoproteins 49 Brain derived neurotrophic 49 Low density lipoprotein 49 transgenic mouse models 49 STAT4 49 triglyceride concentrations 49 proteinuria 49 dysbindin 49 metabolic abnormality 49 subarachnoid haemorrhage 49 overactive bladder symptoms 49 Inhibin B 49 hyperalgesia 49 kyphosis 49 lesional 49 familial AF 49 inherited neurological disorder 49 β blockers 49 asymptomatic PAD 49 untreated celiac disease 49 mice genetically altered 49 SSc 49 prognostic significance 49 myotonic dystrophy 49 dopaminergic therapy 49 airway inflammation 49 NF1 49 IUGR 49 cardiovascular disease hypertension 49 ABCB1 49 tic severity 49 calcium homeostasis 49 striatal dopamine 49 neurosensory 49 LVEF 49 olfactory dysfunction 49 aminotransferase levels 49 calcium supplementation 49 hemolysis 49 advanced adenoma 49 LXRs 49 5 HTTLPR 49 Cockayne syndrome 49 cellular senescence 49 neuromotor 49 mGluR2 NAM 49 ApoA1 49 HRQOL 49 plasma cortisol 49 tau phosphorylation 49 APOE e4 gene 49 Epidemiologic studies 49 leukoencephalopathy 49 adiponectin concentrations 49 FASPS 49 airway reactivity 49 haemorrhagic strokes 49 poorer prognosis 49 AVODART 49 PsA 49 variceal bleeding 49 POAG 49 Frontal lobe 49 retinitis pigmentosa RP 49 lymphatic cancers 49 Alzheimer disease AD 49 ADAS Cog 49 distensibility 49 serum uric acid 49 pathologic fractures 49 univariate analyzes 49 lymphocyte activation 49 serum homocysteine 49 premenopause 49 shorter telomere length 49 Sirt1 49 pyridostigmine 49 frequent awakenings 49 abnormal lipid 49 narcolepsy cataplexy 49 liver histology 49 FGF# 49 EAAT2 49 caudate 49 neurologic progression 49 allele 49 pressor response 49 activin 49 overt hypothyroidism 49 recurrent acute pancreatitis 49 cyclooxygenase 2 49 clinically meaningful improvements 49 hypercholesterolemic patients 49 detrusor overactivity 49 chromosomal instability 49 losartan 49 Degenerative disc disease 49 S#A# [002] 49 serotonin transporter 49 psychiatric comorbidity 49 metabolic derangements 49 neuropsychological deficits 49 prolonged QT interval 49 serum concentrations 49 extrapyramidal 49 Becker muscular dystrophy 49 Sacktor 49 hypoglycemic episodes 49 thromboembolic 49 motoneurons 49 leptin deficiency 49 azoospermia 49 intensive statin therapy 49 AST ALT 49 cognitive domains 49 serum sodium 49 N acetylaspartate 49 autoimmune thyroid 49 biochemical abnormalities 49 osteoblast 49 leptin concentrations 49 postnatally 49 mineral density 49 mitochondrial fusion 49 akinesia 49 coronary artery disease 49 hydroxyvitamin D levels 49 ductal adenocarcinoma 49 diabetic rats 49 lung edema 49 comorbidity 49 E selectin 49 tertile 49 serum bicarbonate 49 ADHD symptoms 49 neurologic disorder 49 radiographic progression 49 femoral neck BMD 49 catabolism 49 neuronal plasticity 49 clinically meaningful improvement 49 serum selenium 49 tumor shrinkage 49 neuritic 49 colon tumors 49 heart disease 49 neuron degeneration 49 conditional logistic regression 49 prolactin elevation 49 sensory disturbances 49 inversely associated 49 Prolactin 49 undiagnosed sleep apnea 49 airway responsiveness 49 chronic renal insufficiency 49 ischaemia 49 PPAR γ 49 transgene expression 49 macrophage infiltration 49 intracranial stenosis 49 juvenile idiopathic arthritis 49 Treated mice 49 MAO B 49 ApoE gene 49 BMI z 49 fibrotic disease 49 transferrin saturation 49 myelogenous leukemia 49 lipid parameters 49 triglyceride levels 49 thyrotoxicosis 49 leptin hormone 49 serum triglyceride 49 clioquinol 49 intracerebral haemorrhage 49 vasomotor symptoms 49 intestinal microflora 49 ERK signaling 49 fatty infiltration 49 Singh Manoux 49 myocardial reperfusion 49 PKC beta 49 hyperparathyroidism 49 coronary microvascular 49 habitual snoring 49 hypometabolism 49 osteopenic 49 thyroxine 49 intractable epilepsy 49 TZDs 49 cachexia 49 Fasting plasma glucose 49 lung metastasis 49 hemoglobin A1c levels 49 muscle rigidity 49 blood Phe levels 49 retinal edema 49 QTc prolongation 49 methylation patterns 49 GH deficient 49 TEAEs 49 abdominal fat 48 systolic blood pressure 48 temporal cortex 48 neurological dysfunction 48 primary biliary cirrhosis 48 morphometric vertebral fractures 48 hyperactivation 48 pre pubertal